We are live on ! Find out more
CRB

Chad R. Baker Portfolio holdings

AUM $620M
1-Year Est. Return 42.67%
This Fund
S&P 500
This Quarter Est. Return
+7.2%
1 Year Est. Return
+42.67%
3 Year Est. Return
+108.31%
5 Year Est. Return
+132.07%
10 Year Est. Return
+563.15%
AUM
$509M
AUM Growth
+$30M
Cap. Flow
+$856K
Cap. Flow %
0.17%
Top 10 Hldgs %
45.87%
Holding
53
New
2
Increased
5
Reduced
9
Closed
3

Top Buys

Rank Stock Value
1
ULS icon
UL Solutions
ULS
+$2.86M
2
ALC icon
Alcon
ALC
+$2.68M
3
RELX icon
RELX
RELX
+$2.63M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$2.21M
5
MKC icon
McCormick & Company Non-Voting
MKC
+$383K

Top Sells

Rank Stock Value
1
WIRE
Encore Wire Corp
WIRE
+$3.77M
2
AAPL icon
Apple
AAPL
+$3.35M
3
CNI icon
Canadian National Railway
CNI
+$1.56M
4
FTV icon
Fortive
FTV
+$1.11M
5
CARR icon
Carrier Global
CARR
+$283K

Sector Composition

Rank Sector Weight
1 Technology 32.4%
2 Industrials 19.43%
3 Healthcare 17.82%
4 Consumer Discretionary 11.34%
5 Communication Services 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NYT icon
26
New York Times
NYT
$11B
$7.98M 1.57%
143,325
NET icon
27
Cloudflare
NET
$107B
$7.76M 1.52%
95,900
LOW icon
28
Lowe's Companies
LOW
$117B
$7.61M 1.5%
28,100
TJX icon
29
TJX Companies
TJX
$149B
$7.33M 1.44%
62,340
HD icon
30
Home Depot
HD
$329B
$7.15M 1.4%
17,635
SYK icon
31
Stryker
SYK
$127B
$6.9M 1.36%
19,095
-50
-0.3% -$17.3K
CL icon
32
Colgate-Palmolive
CL
$72.3B
$5.32M 1.04%
51,200
ZTS icon
33
Zoetis
ZTS
$32B
$4.85M 0.95%
24,818
CRSP icon
34
CRISPR Therapeutics
CRSP
$5.58B
$4.66M 0.92%
99,280
+760
+0.8% +$38.6K
ADBE icon
35
Adobe
ADBE
$116B
$4.66M 0.92%
9,000
RTX icon
36
RTX Corp
RTX
$285B
$4.65M 0.91%
38,348
VRTX icon
37
Vertex Pharmaceuticals
VRTX
$137B
$4.53M 0.89%
9,740
+4,595
+89% +$2.21M
GOOG icon
38
Alphabet (Google) Class C
GOOG
$4.19T
$3.69M 0.73%
22,100
CSX icon
39
CSX Corp
CSX
$95B
$3.52M 0.69%
102,000
ULS icon
40
UL Solutions
ULS
$15B
$2.9M 0.57%
+58,800
New +$2.86M
RELX icon
41
RELX
RELX
$63.6B
$2.69M 0.53%
+56,775
New +$2.63M
MRK icon
42
Merck
MRK
$366B
$2.46M 0.48%
21,700
CI icon
43
Cigna
CI
$73.7B
$2.02M 0.4%
5,841
XOM icon
44
ExxonMobil
XOM
$644B
$1.92M 0.38%
16,400
MKC icon
45
McCormick & Company Non-Voting
MKC
$14.9B
$1.29M 0.25%
15,625
+4,910
+46% +$383K
NVDA icon
46
NVIDIA
NVDA
$5.25T
$1.28M 0.25%
10,500
-250
-2% -$29.5K
APTV icon
47
Aptiv
APTV
$9.5B
$1.07M 0.21%
14,845
BDX icon
48
Becton Dickinson
BDX
$51.6B
$1.06M 0.21%
4,385
+1,365
+45% +$320K
PFE icon
49
Pfizer
PFE
$159B
$709K 0.14%
24,500
NVO
50
Novo Nordisk
NVO
$202B
$617K 0.12%
5,180
-200
-4% -$26.7K

Similar funds

Chad R. Baker's Q3 2024 Portfolio in Review

As of Q3 2024, Chad R. Baker held 53 positions worth $509M, up 6.3% from $479M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Chad R. Baker's Q3 2024 filing shows 2 new, 5 increased, 9 reduced and 3 closed positions. Its largest new stake was UL Solutions: 58,800 shares worth $2.9M. The largest sale was Encore Wire Corp, an estimated $3.77M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Industrials and Healthcare.

  • Chad R. Baker's largest Q3 2024 buy was UL Solutions: 58,800 shares worth $2.9M.
  • Chad R. Baker added most to Alcon in Q3 2024, an estimated $2.68M increase.
  • Chad R. Baker's biggest Q3 2024 reduction was Apple, cutting an estimated $3.35M.
  • Chad R. Baker fully exited Encore Wire Corp in Q3 2024, selling an estimated $3.77M.
  • Chad R. Baker's ten largest holdings make up 46% of its $509M portfolio in Q3 2024.
  • Chad R. Baker opened 2 new positions and closed 3 in Q3 2024.
  • Chad R. Baker's portfolio value rose 6.3% quarter-over-quarter to $509M.

Based on Chad R. Baker's 13F filing for Q3 2024, filed 18 Oct 2024.